Novel Pyrazolo[3,4-d]pyrimidin-4-one Derivatives as Potential Antifungal Agents: Design, Synthesis, and Biological Evaluation. 2021

Xiang Cheng, and Wei Wang, and Yunxiao Wang, and Dongguo Xia, and Fang Yin, and Qiaoyun Liu, and Huisheng Luo, and Meng Li, and Chengqi Zhang, and Haiqun Cao, and Xianhai Lv
School of Science, Anhui Agricultural University, Hefei 230036, China.

Plant pathogenic fungi seriously threaten agricultural production. There is an urgent need to develop novel fungicides with low toxicity and high efficiency. In this study, we designed and synthesized 44 pyrazolo[3,4-d]pyrimidin-4-one derivatives and evaluated them for their fungicidal activities. The bioassay data revealed that most of the target compounds possessed moderate to high in vitro antifungal activities. Especially compound g22 exhibited remarkable antifungal activity against Sclerotinia sclerotiorum with an EC50 value of 1.25 mg/L, close to that of commercial fungicide boscalid (EC50 = 0.96 mg/L) and fluopyram (EC50 = 1.91 mg/L). Moreover, compound g22 possessed prominent protective activity against S. sclerotiorum in vivo for 24 h (95.23%) and 48 h (93.78%), comparable to positive control boscalid (24 h (96.63%); 48 h (93.23%)). Subsequent studies indicated that compound g22 may impede the growth and reproduction of S. sclerotiorum by affecting the morphology of mycelium, destroying cell membrane integrity, and increasing cell membrane permeability. In addition, the application of compound g22 did not injure the growth or reproduction of Italian bees. This study revealed that compound g22 is expected to be developed for efficient and safe agricultural fungicides.

UI MeSH Term Description Entries
D005659 Fungicides, Industrial Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. Industrial Fungicides
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D001203 Ascomycota A phylum of fungi which have cross-walls or septa in the mycelium. The perfect state is characterized by the formation of a saclike cell (ascus) containing ascospores. Most pathogenic fungi with a known perfect state belong to this phylum. Ascomycetes,Cochliobolus,Sclerotinia,Ascomycete,Ascomycotas,Sclerotinias
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Xiang Cheng, and Wei Wang, and Yunxiao Wang, and Dongguo Xia, and Fang Yin, and Qiaoyun Liu, and Huisheng Luo, and Meng Li, and Chengqi Zhang, and Haiqun Cao, and Xianhai Lv
August 2022, Bioorganic & medicinal chemistry letters,
Xiang Cheng, and Wei Wang, and Yunxiao Wang, and Dongguo Xia, and Fang Yin, and Qiaoyun Liu, and Huisheng Luo, and Meng Li, and Chengqi Zhang, and Haiqun Cao, and Xianhai Lv
January 2016, Journal of pharmacy & bioallied sciences,
Xiang Cheng, and Wei Wang, and Yunxiao Wang, and Dongguo Xia, and Fang Yin, and Qiaoyun Liu, and Huisheng Luo, and Meng Li, and Chengqi Zhang, and Haiqun Cao, and Xianhai Lv
August 2008, Journal of agricultural and food chemistry,
Xiang Cheng, and Wei Wang, and Yunxiao Wang, and Dongguo Xia, and Fang Yin, and Qiaoyun Liu, and Huisheng Luo, and Meng Li, and Chengqi Zhang, and Haiqun Cao, and Xianhai Lv
April 2007, Bioorganic & medicinal chemistry letters,
Xiang Cheng, and Wei Wang, and Yunxiao Wang, and Dongguo Xia, and Fang Yin, and Qiaoyun Liu, and Huisheng Luo, and Meng Li, and Chengqi Zhang, and Haiqun Cao, and Xianhai Lv
March 2014, Molecules (Basel, Switzerland),
Xiang Cheng, and Wei Wang, and Yunxiao Wang, and Dongguo Xia, and Fang Yin, and Qiaoyun Liu, and Huisheng Luo, and Meng Li, and Chengqi Zhang, and Haiqun Cao, and Xianhai Lv
August 2016, Bioorganic chemistry,
Xiang Cheng, and Wei Wang, and Yunxiao Wang, and Dongguo Xia, and Fang Yin, and Qiaoyun Liu, and Huisheng Luo, and Meng Li, and Chengqi Zhang, and Haiqun Cao, and Xianhai Lv
April 2010, European journal of medicinal chemistry,
Xiang Cheng, and Wei Wang, and Yunxiao Wang, and Dongguo Xia, and Fang Yin, and Qiaoyun Liu, and Huisheng Luo, and Meng Li, and Chengqi Zhang, and Haiqun Cao, and Xianhai Lv
October 2010, Journal of enzyme inhibition and medicinal chemistry,
Xiang Cheng, and Wei Wang, and Yunxiao Wang, and Dongguo Xia, and Fang Yin, and Qiaoyun Liu, and Huisheng Luo, and Meng Li, and Chengqi Zhang, and Haiqun Cao, and Xianhai Lv
March 2006, Bioorganic & medicinal chemistry,
Xiang Cheng, and Wei Wang, and Yunxiao Wang, and Dongguo Xia, and Fang Yin, and Qiaoyun Liu, and Huisheng Luo, and Meng Li, and Chengqi Zhang, and Haiqun Cao, and Xianhai Lv
June 2023, RSC advances,
Copied contents to your clipboard!